BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 8543829)

  • 21. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM; van Es LA; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens.
    Norrby-Teglund A; Ihendyane N; Kansal R; Basma H; Kotb M; Andersson J; Hammarström L
    Clin Infect Dis; 2000 Nov; 31(5):1175-82. PubMed ID: 11073749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of some immunological parameters in pulmonary tuberculosis].
    Dubaniewicz A; Sztaba-Kania M; Hoppe A
    Pol Merkur Lekarski; 2004 Feb; 16(92):123-7. PubMed ID: 15176294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.
    Zhang W; Lachmann PJ
    Immunology; 1994 Jan; 81(1):137-41. PubMed ID: 8132210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of mouse complement by different classes of mouse antibody.
    Klaus GG; Pepys MB; Kitajima K; Askonas BA
    Immunology; 1979 Dec; 38(4):687-95. PubMed ID: 521057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.
    Basta M; Kirshbom P; Frank MM; Fries LF
    J Clin Invest; 1989 Dec; 84(6):1974-81. PubMed ID: 2687331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of lectin pathway haemolysis by immunoglobulins.
    Suankratay C; Zhang Y; Jones D; Lint TF; Gewurz H
    Clin Exp Immunol; 1999 Sep; 117(3):435-41. PubMed ID: 10469044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
    Phiri IK; Phiri AM; Harrison LJ
    Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes.
    Van den Berg CW; Hazenberg MA; Hofhuis FM; Van Rooyen SM; Van Dijk H
    Immunology; 1991 Jul; 73(3):264-70. PubMed ID: 1879875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation.
    Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
    Mol Immunol; 1990 May; 27(5):423-8. PubMed ID: 2366759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
    Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
    Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunological aspects of sickle cell syndrome with particular reference to circulating immune complexes.
    Kazeem AA
    East Afr Med J; 1990 Nov; 67(11):761-9. PubMed ID: 2076676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of IgM rheumatoid factor in experimental immune vasculitis.
    Floyd M; Tesar JT
    Clin Exp Immunol; 1979 Apr; 36(1):165-74. PubMed ID: 157238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of persistent IgA/IgG circulating immune complexes associated with activation of the complement system in serum of a patient with common variable immune deficiency: anaphylactic reactions to intravenous gammaglobulin.
    Wahn V; Good RA; Gupta S; Pahwa S; Day NK
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():49-58. PubMed ID: 6203331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.